Payment overview · 2025
General Payments
$25.50
1 reported records · 1 companies
Healthcare provider profile · identity verified
Rajesh Jindal, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · WILMETTE, IL · NPI 1184818791
Verified facts
What the public records show
CMS Open Payments records show Rajesh Jindal, M.D. received $25.50 in general payments during 2025 across 1 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $25.50 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $25.50 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25.50 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1020 | 155 |
| Eliquis | Apixaban | 590 | 62 |
| Levothyroxine Sodium | Levothyroxine Sodium | 580 | 86 |
| Amlodipine Besylate | Amlodipine Besylate | 536 | 95 |
| Gabapentin | Gabapentin | 484 | 64 |
| Furosemide | Furosemide | 421 | 75 |
| Omeprazole | Omeprazole | 418 | 70 |
| Sertraline Hcl | Sertraline Hcl | 415 | 30 |
| Mirtazapine | Mirtazapine | 390 | 47 |
| Memantine Hcl | Memantine Hcl | 382 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 361 | 45 |
| Donepezil Hcl | Donepezil Hcl | 341 | 29 |
| Lisinopril | Lisinopril | 284 | 42 |
| Tamsulosin Hcl | Tamsulosin Hcl | 280 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 276 | 49 |
| Potassium Chloride | Potassium Chloride | 273 | 42 |
| Losartan Potassium | Losartan Potassium | 259 | 54 |
| Metoprolol Succinate | Metoprolol Succinate | 259 | 46 |
| Quetiapine Fumarate | Quetiapine Fumarate | 256 | 38 |
| Duloxetine Hcl | Duloxetine Hcl | 255 | 23 |
| Metformin Hcl | Metformin Hcl | 240 | 35 |
| Carvedilol | Carvedilol | 238 | 34 |
| Trazodone Hcl | Trazodone Hcl | 222 | 28 |
| Famotidine | Famotidine | 184 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 177 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 172 | 42 |
| Buspirone Hcl | Buspirone Hcl | 160 | suppressed |
| Spironolactone | Spironolactone | 155 | 24 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 144 | 14 |
| Jardiance | Empagliflozin | 143 | 25 |
| Xarelto | Rivaroxaban | 135 | 11 |
| Montelukast Sodium | Montelukast Sodium | 134 | 19 |
| Finasteride | Finasteride | 129 | 17 |
| Risperidone | Risperidone | 125 | 11 |
| Warfarin Sodium | Warfarin Sodium | 117 | suppressed |
| Bumetanide | Bumetanide | 116 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 107 | 31 |
| Latanoprost | Latanoprost | 103 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 99 | suppressed |
| Digoxin | Digoxin | 98 | suppressed |
| Glimepiride | Glimepiride | 97 | suppressed |
| Simvastatin | Simvastatin | 96 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 95 | suppressed |
| Levetiracetam | Levetiracetam | 94 | 15 |
| Baclofen | Baclofen | 89 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 88 | 34 |
| Clopidogrel | Clopidogrel Bisulfate | 85 | 17 |
| Propranolol Hcl | Propranolol Hcl | 85 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 83 | 12 |
| Olanzapine | Olanzapine | 83 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 81 | 11 |
| Colchicine | Colchicine | 79 | suppressed |
| Celecoxib | Celecoxib | 78 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 76 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 74 | 15 |
| Allopurinol | Allopurinol | 73 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 71 | 24 |
| Meloxicam | Meloxicam | 69 | 16 |
| Enoxaparin Sodium | Enoxaparin Sodium | 64 | suppressed |
| Prednisone | Prednisone | 64 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 63 | 31 |
| Enalapril Maleate | Enalapril Maleate | 63 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 62 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 61 | 15 |
| Jantoven | Warfarin Sodium | 60 | suppressed |
| Atenolol | Atenolol | 59 | suppressed |
| Januvia | Sitagliptin Phosphate | 59 | suppressed |
| Nifedipine Er | Nifedipine | 58 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 57 | suppressed |
| Entresto | Sacubitril/Valsartan | 56 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 50 | suppressed |
| Bupropion Xl | Bupropion Hcl | 49 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 49 | suppressed |
| Cephalexin | Cephalexin | 47 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 45 | 13 |
| Brimonidine Tartrate | Brimonidine Tartrate | 44 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 44 | 17 |
| Lamotrigine | Lamotrigine | 43 | suppressed |
| Lubiprostone | Lubiprostone | 43 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 43 | 17 |
| Rexulti | Brexpiprazole | 43 | suppressed |
| Aripiprazole | Aripiprazole | 42 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 42 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 41 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 41 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 40 | suppressed |
| Methylprednisolone | Methylprednisolone | 40 | 30 |
| Myrbetriq | Mirabegron | 40 | suppressed |
| Levofloxacin | Levofloxacin | 39 | 22 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 38 | 12 |
| Clonidine Hcl | Clonidine Hcl | 38 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 38 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 38 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 17 |
| Azithromycin | Azithromycin | 37 | 28 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 36 | suppressed |
| Rifampin | Rifampin | 36 | suppressed |
| Amantadine | Amantadine Hcl | 35 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 35 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 35 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 34 | 22 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 34 | suppressed |
| Metolazone | Metolazone | 34 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 33 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 33 | 19 |
| Farxiga | Dapagliflozin Propanediol | 32 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 32 | suppressed |
| Topiramate | Topiramate | 32 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 31 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 31 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 30 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 30 | suppressed |
| Trulicity | Dulaglutide | 30 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 29 | suppressed |
| Nystatin | Nystatin | 29 | 19 |
| Alendronate Sodium | Alendronate Sodium | 28 | suppressed |
| Clozapine | Clozapine | 28 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 27 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 27 | suppressed |
| Loperamide | Loperamide Hcl | 27 | 12 |
| Alprazolam | Alprazolam | 26 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | suppressed |
| Methimazole | Methimazole | 26 | suppressed |
| Methotrexate | Methotrexate Sodium | 26 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 25 | 13 |
| Ezetimibe | Ezetimibe | 24 | suppressed |
| Felodipine Er | Felodipine | 24 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Lorazepam | Lorazepam | 24 | suppressed |
| Sucralfate | Sucralfate | 24 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 23 | 22 |
| Lovastatin | Lovastatin | 23 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 23 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 23 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 22 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 22 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 22 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 22 | suppressed |
| Calcitriol | Calcitriol | 21 | suppressed |
| Klor-Con M20 | Potassium Chloride | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | 13 |
| Pregabalin | Pregabalin | 21 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 21 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 21 | suppressed |
| Budesonide | Budesonide | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 20 | suppressed |
| Sumatriptan | Sumatriptan | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 14 |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 19 | suppressed |
| Timolol Maleate | Timolol Maleate | 18 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 17 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 16 | suppressed |
| Lactulose | Lactulose | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Rivastigmine | Rivastigmine | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 13 |
| Ozempic | Semaglutide | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 15 | suppressed |
| Trospium Chloride Er | Trospium Chloride | 15 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Calcium Acetate | Calcium Acetate | 14 | suppressed |
| Mounjaro | Tirzepatide | 14 | suppressed |
| Nicardipine Hcl | Nicardipine Hcl | 14 | suppressed |
| Scopolamine | Scopolamine | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 14 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 13 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 13 | suppressed |
| Estradiol | Estradiol | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Loteprednol Etabonate | Loteprednol Etabonate | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 13 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Calcipotriene | Calcipotriene | 12 | suppressed |
| Hydroxyurea | Hydroxyurea | 12 | suppressed |
| Jentadueto Xr | Linagliptin/Metformin Hcl | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Minoxidil | Minoxidil | 12 | suppressed |
| Nystop | Nystatin | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 12 | suppressed |
| Acetazolamide | Acetazolamide | 11 | suppressed |
| Belsomra | Suvorexant | 11 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 11 | suppressed |
| Carbamazepine Er | Carbamazepine | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Permethrin | Permethrin | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $25.50 · 1 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error